DepYmed Inc. is a New York-based cancer and rare disease therapeutic development company. DepYmed is currently developing potent inhibitors of the enzyme PTP1B (protein tyrosine phosphatase 1B) as potential novel therapeutics for HER2-positive breast cancer and Rett Syndrome.

Pharmaceutical

DepYmed

DepYmed's headquarters in Farmingdale, NY, United States

Andreas G. Grill

Peter Van Ess

Nicholas Tonks

Peter Young

Shankar Hariharan

Steve Winick

Leo Guthart

This department focuses on guiding and enhancing the skills of organizational leaders.

Leadership Development

This department ensures compliance with legal and regulatory requirements while overseeing corporate policies and governance practices.

Corporate Governance

DepYmed's Leadership Team includes Peter Van Ess and 1 others.

DepYmed

Org chart

Board & advisors

Teams

Leadership Development

Corporate Governance

Leadership Team

Offices

DepYmed

Org chart

Board & advisors

Teams

Leadership Development

Corporate Governance

Leadership Team

Offices

Related companies